Upregulation of Caveolin-1 and Cd147 Expression in Nasopharyngeal Carcinoma Enhanced Tumor Cell Migration and Correlated with Poor Prognosis of the Patients

Zi-Ming Du,Chun-Fang Hu,Qiong Shao,Ma-Yan Huang,Chang-Wei Kou,Xiao-Feng Zhu,Yi-Xin Zeng,Jian-Yong Shao
DOI: https://doi.org/10.1002/ijc.24531
2009-01-01
International Journal of Cancer
Abstract:Expression of caveolin-1 (Cav-1) and extracellular matrix metalloproteinase inducer (EMMPRIN/CD147) and their prognostic significance were analyzed in archive NPC samples. Cav-1 and CD147 were overexpressed in 49.48% (96/194) and 59.39% (117/197) of NPC, respectively. Both Cav-1. and CD147 expression levels correlated significantly with metastasis (p = 0.025 and 0.017, respectively) and a lower 5-year survival rate (p = 0.02 and 0.0009, respectively). In addition, Cav-1 expression levels correlated significantly with local recurrence (p = 0.038). Multivariate Cox regression analysis indicated that combination of high Cav-1 and CD147 expression was a significant, independent prognosis predictor in patients with NPC (HR = 2.135; p = 0.006). Functional studies revealed that overexpression of Cav-1 promoted secretion of MMP-3 and MMP-11 (active) proteins, as well as an increase in the migratory ability of CNE1 and CNE2 cells, while siRNA-mediated silencing of Cav-1 or CD 147 led to reduced levels of MMP-3 and MMP-11 (active) secretion, and reduced migration capacity of CNE1 and CNE2 cells. We observed a positive correlation between Cav-1 and CD147 expression in NPC (p = 0.330,p = 0.000), CD147 protein levels were upregulated in Cav-1 overexpressing CNE1 and CNE2 cells, whereas siRNA-mediated silencing of Cav-1 led to the downregulation of CD147 expression. Our results indicate that Cav-1 and CD147 overexpression predict poor NPC prognosis and enhanced tumor cell migration, which is associated with MMP-3 and MMP-11 (active) secretion. (C) 2009 UICC
What problem does this paper attempt to address?